Gómez Portilla Alberto, Cendoya Ignacio, Olabarria Ignacio, Echevarría Jesús, Martínez de Lecea Concepción, Romero Erika, Guede Nerea, Moraza Nuria, Fernández Elena, Kvadatze Mijail, Larrabide Iñaki, Valdovinos Mercedes, Ruiz de Alegría Natalia, Fernández José Luis, Castillo Carlos
Programa de Carcinomatosis Peritoneal, Servicio de Cirugía, Hospital San José, Vitoria-Gasteiz, Alava, España.
Cir Esp. 2008 Oct;84(4):215-20. doi: 10.1016/s0009-739x(08)72622-8.
The use of a new therapeutic alternative involving cytoreductive surgery with perioperative intraperitoneal chemotherapy in the treatment of patients suffering from peritoneal carcinomatosis represents a new challenge for the multidisciplinary teams caring for these patients. Their post-operative progress and care needs, apart from differing from those of conventional patients, have not yet been completely defined or protocolised. In this presentation we explain the special characteristics of these patients compared to the usual surgical patients, the possible physiopathological mechanisms which may give rise to the different types of complications, the circumstances when a temporary abdominal closure is necessary, the ideal conditions required for an optimal technique, and finally our experience with the open vacuum abdomen technique in the treatment of the complications that appear in patients treated by this new triple combined therapy.
Based on our personal experience in the treatment of 110 cytoreductions carried out between February 1997 and February 2007 on 71 patients suffering from peritoneal carcinomatosis of various origins. Of the 71 patients, 50 (70%) suffered some kind of complication during their postoperative evolution, 28 of them requiring re-operation for a Grade III-IV postoperative complication. The abdominal situation made a temporary closure desirable in 17 patients, having applied an open vacuum abdomen technique on every occasion. We study this group of patients according their original type of tumour and stage of the disease at the cytoreductive procedure, peritonectomies and visceral resections required, type of postoperative complications, treatment applied and evolution.
A total of 52 open vacuum abdomen procedures were required (median, 2.8 per patient; range, 1-10) before the abdominal complication could be completely kept under control in these 17 patients. Only 2 postoperative intestinal fistulas were directly related to this technique, and a primary closure of the whole abdominal wall was possible in 11 of these patients (66%). All but one of them left the hospital alive and well.
As a consequence of this experience, in our opinion, the open vacuum abdomen is the ideal election technique to be employed in any temporary closure of the abdominal cavity for whatever reason it is required, including the worst possible surgical scenario, as we have demonstrated in the treatment of surgical complications after cytoreductive procedures and intraperitoneal chemohyperthermia.
采用一种新的治疗方法,即减瘤手术联合围手术期腹腔内化疗来治疗腹膜癌患者,这对护理这些患者的多学科团队而言是一项新挑战。他们术后的病情进展和护理需求,不仅与传统患者不同,而且尚未完全明确或形成规范流程。在本报告中,我们阐述了这些患者相较于普通外科患者的特殊特征、可能引发不同类型并发症的生理病理机制、需要进行临时腹部关闭的情况、最佳技术所需的理想条件,最后介绍了我们在采用这种新的三联联合疗法治疗的患者中,运用开放式真空腹部技术处理出现的并发症的经验。
基于我们在1997年2月至2007年2月期间对71例不同病因的腹膜癌患者进行110次减瘤手术的个人经验。在这71例患者中,50例(70%)在术后病情演变过程中出现了某种并发症,其中28例因Ⅲ - Ⅳ级术后并发症需要再次手术。腹部情况使得17例患者需要进行临时关闭,每次均采用了开放式真空腹部技术。我们根据患者肿瘤的原始类型、减瘤手术时疾病的分期、所需的腹膜切除和脏器切除、术后并发症类型、所采用的治疗方法及病情演变对这组患者进行研究。
在这17例患者中,共需要进行52次开放式真空腹部手术(中位数为每位患者2.8次;范围为1 - 10次),才能完全控制腹部并发症。仅有2例术后肠瘘与该技术直接相关,其中11例患者(66%)能够对整个腹壁进行一期缝合。除1例患者外,其他患者均康复出院。
基于这一经验,我们认为,无论出于何种原因需要临时关闭腹腔,包括在最糟糕的手术情况下,开放式真空腹部技术都是理想的选择,正如我们在减瘤手术和腹腔内热灌注化疗后的手术并发症治疗中所证明的那样。